I agree with your business analysis, though I take no position on "green man bad." I'd add to your analysis that, given the immediate IPO-driven need to demons

I agree with your business analysis, though I take no position on "green man bad." I'd add to your analysis that, given the immediate IPO-driven need to demonstrate they can increase margins, raising prices sooner is probably better than later because RISC-V is not yet a viable competitive alternative for ARM's most attractive customers. However, later it very likely will be and if RISC-V proves to be a threat to ARM's blended margins, ARM can drop prices then because at least the IPO will be over.